☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Ligand Pharmaceuticals
Ligand Pharmaceuticals Reports the Acquisition of APEIRON Biologics for $100M
July 9, 2024
PharmaShots Weekly Snapshots (January 08 – January 12, 2024)
January 15, 2024
Ligand Pharmaceuticals’ Zelsuvmi Receives the US FDA’s Approval for the Treatment of Molluscum Contagiosum
January 8, 2024
Load more...
Back to Home
Modal title
×
Modal body text goes here.
